We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MIST market cap is 123.19M. The company's latest EPS is USD -1.1192 and P/E is -1.97.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.36M | -13.8M | -10.48M | -9.66M | -9.62M |
| Net Income | -15.08M | -13.61M | -10.35M | -9.36M | -9.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 15M | 5M | 1M |
| Operating Income | -57.88M | -50.71M | -43.07M | -59.64M | -61.1M |
| Net Income | -55.23M | -49.97M | -42.85M | -58.39M | -59.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 87.12M | 75.23M | 96M | 89.23M | 82.71M |
| Total Liabilities | 58.61M | 58.46M | 56.08M | 57.25M | 58.69M |
| Total Equity | 28.5M | 16.77M | 39.92M | 31.98M | 24.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 123.43M | 149.97M | 119.85M | 74.48M | 75.23M |
| Total Liabilities | 8.51M | 6.86M | 7.25M | 8.14M | 58.46M |
| Total Equity | 114.92M | 143.12M | 112.6M | 66.35M | 16.77M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -36.63M | -46.42M | -8.93M | -14.99M | -22.01M |
| Investing | -8.92M | 4.76M | -27.01M | -17.53M | -11.05M |
| Financing | 47.79M | 47.79M | 32.32M | 32.02M | 32.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -51.15M | -50.73M | -33.22M | -52.47M | -46.42M |
| Investing | -384k | -70M | 70M | -57.12M | 4.76M |
| Financing | 85.41M | 73.22M | 5.06M | 3.09M | 47.79M |
| Market Cap | 123.19M |
| Price to Earnings Ratio | -1.97 |
| Price to Sales Ratio | 117.02 |
| Price to Cash Ratio | 8.53 |
| Price to Book Ratio | 7 |
| Dividend Yield | - |
| Shares Outstanding | 53.33M |
| Average Volume (1 week) | 772.6k |
| Average Volume (1 Month) | 579.74k |
| 52 Week Change | 35.09% |
| 52 Week High | 2.75 |
| 52 Week Low | 1.12 |
| Spread (Intraday) | 0.29 (12.08%) |
| Company Name | Milestone Pharmaceuticals Inc |
| Address |
1111 dr.-frederik-philips blvd., suite 420 montreal, quebec H4M 2X6 |
| Website | https://www.milestonepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
